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Research in Translation
I
diopathic pulmonary ﬁbrosis (IPF) 
is a chronic, progressive, and 
usually lethal disease of uncertain 
etiology [1]. It has been proposed that 
IPF likely results from an aberrant 
activation of alveolar epithelial cells 
after injury that provoke the migration, 
proliferation, and activation of 
mesenchymal cells with the formation 
of ﬁbroblastic/myoﬁbroblastic 
foci, leading to the exaggerated 
accumulation of extracellular matrix 
with the irreversible destruction of 
the lung parenchyma [2–4]. The 
molecular mechanisms that determine 
the persistent nature of IPF are poorly 
understood. While aberrant activation 
of developmental pathways that are 
usually suppressed in adult tissues is 
often noticed in cancer, it is only rarely 
observed in non-malignant diseases. 
In the following pages we present 
evidence from gene expression studies 
and animal models of disease that 
suggest that IPF is characterized by 
aberrant activation of developmental 
pathways (Box 1). 
Transcriptional Signatures of 
IPF Lungs Are Enriched with 
Developmental Genes
Microarray analysis identiﬁed an IPF-
speciﬁc gene expression signature 
characterized by the up-regulation 
of genes indicative of an active tissue 
remodeling program, including 
extracellular matrix and a large 
number of myoﬁbroblast/smooth 
muscle cell–associated and epithelial 
cell–related genes [3,5]. Recently, we 
have reanalyzed previously published 
datasets [3,5,6] using analytical 
approaches that allow global and 
unbiased mapping of the functional 
themes that characterize IPF lungs 
in comparison to controls or to 
other interstitial lung disease. The 
analyses revealed that IPF lungs were 
signiﬁcantly enriched with genes 
associated with lung development [7]. 
The up-regulated development-relevant 
genes included several members of 
transcription factor families such as the 
Sry-related high mobility group box 
and forkhead box, and genes related to 
the Wnt/β-catenin pathway [6,7]. (For 
complete datasets see http: //www.
dom.pitt.edu/paccm/Genomics/data.
htm).
While transcription factors active in 
morphogenesis and differentiation of 
the embryonic lung may be transiently 
expressed during adult lung repair, as 
in naphthalene injury [8], they are only 
rarely expressed in the normal lung. In 
fact, their sustained expression is often 
thought of as a marker for malignant 
transformation.
Epithelial Cell Plasticity 
Epithelial cells are motile and can 
migrate away from their nearest 
neighbors [9]. However, under normal 
conditions they do not detach and 
move away from the epithelial layer. 
This arrangement can be disturbed 
by a process known as epithelial–
mesenchymal transition (EMT). In the 
process of EMT, epithelial cells lose 
many of their epithelial characteristics 
and obtain properties that are 
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Summary Points
• Idiopathic pulmonary ﬁbrosis is a 
devastating lung disorder of unknown 
etiology that inexorably leads to death 
in a relatively short time because of the 
lack of any effective therapy.
• IPF lungs are enriched with genes 
associated with lung development, 
indicating that embryonic signaling 
pathways involved in epithelium/
mesenchymal communication and 
epithelial cell plasticity may be 
aberrantly activated in this disease. 
• Developmental genes include 
members of transcription factor 
families such as the Sry-related high 
mobility group–box and forkhead 
box, and genes related to the Wnt/β-
catenin pathway.
• Epithelial-to-mesenchymal transition, 
a key process in embryogenesis, 
may contribute to the ﬁbroblast 
expansion in IPF lungs. Diverse 
molecular networks in IPF lungs 
seem to constitute an environment 
that drives epithelial cells to express 
mesenchymal cell properties.
• A better understanding of the 
dysfunctional activation of 
embryological pathways in IPF 
may result in novel, more effective 
therapeutic strategies.
Research in Translation discusses health interventions 
in the context of translation from basic to clinical 
research, or from clinical evidence to practice.PLoS Medicine  |  www.plosmedicine.org 0374 March 2008  |  Volume 5  |  Issue 3  |  e62
Table 1. Developmental-Associated Differentially Expressed Genes in Idiopathic Pulmonary Fibrosis Compared With Normal Lungs
Gene Bank 
Accession Number
Gene Name t-Test p-Value Fold Change
Wnt pathway
NM_000474 Twist homolog (Acrocephalosyndactyly) 3; (Drosophila) (TWIST) 4.78E-05 1.93341
NM_003212 Teratocarcinoma-derived growth factor 1 (TDGF1) 0.0107412 1.35966
NM_003012 Secreted frizzled-related protein 1 (SFRP1) 0.000858651 1.12698
AF213459 Ephrin receptor EPHA3  0.00334424 1.09625
AF288571 Lymphoid enhancer factor-1 (LEF-1) 0.00195794 0.677595
NM_004442 EPHB2 (EPHB2), Transcript variant 1 0.00405986 0.644545
NM_003507 Frizzled homolog 7 (Drosophila) (FZD7) 0.0156188 0.60387
NM_007197 Frizzled homolog 10 (Drosophila) (FZD10) 0.0338039 0.52155
NM_133631 Roundabout, axon guidance receptor, homolog 1 (Drosophila) (ROBO1), transcript variant 2 0.00105506 0.480198
NM_003391 Wingless-type MMTV integration site family member 2 (Wnt2) 0.0232113 0.417606
NM_003392 Wingless-type MMTV integration site family member 5A (Wnt5a) 0.0389131 0.403205
NM_004560 Tyrosine kinase-like orphan receptor 2 (ROR2) 0.00834763 0.381742
NM_003506 Frizzled homolog 6 (Drosophila) (FZD6) 0.00884951 0.369912
TGF-beta/BMP
NM_003239 Transforming growth factor, beta 3 4.68E-07 1.4875
NM_001200 Bone morphogenetic protein-2 (BMP-2) 0.00547695 -1.21824
NM_001202 Bone morphogenetic protein-4 (BMP-4) 0.0148047 1.04239
BC014890 Homo sapiens, SLUG (chicken homolog), zinc ﬁnger protein 7.01E-05 0.97068
NM_005900 Mothers against decapentaplegic homolog 1 (Drosophila) (MADH1) 0.00871333 0.803222
X16323 Human hepatocyte growth factor (HGF) 3.32E-05 0.802943
AF288571 Lymphoid enhancer factor-1 (LEF-1) 0.00195794 0.677595
NM_005811 Growth differentiation factor 11 (GDF11) 0.00281541 0.56108
NM_005901 Mothers against decapentaplegic homolog 2 (Drosophila) (MADH2) 0.029944 0.442093
Other developmental-associated genes
NM_000095 Cartilage oligomeric matrix protein (Pseudochondroplasia, epiphyseal dysplasia 1, multiple) 9.58E-06 2.45674
X57025 Human insulin growth factor I 2.29E-06 2.19103
NM_013999 Mesenchyme homeobox 1 (MEOX1) 0.000279491 1.4691
NM_002632 Placental growth factor, vascular endothelial growth factor-related protein (PGF) 0.000172092 1.2262
NM_000138 Fibrillin 1 (Marfan syndrome) (FBN1) 0.00510626 1.18922
NM_021170 BHLH factor HES4 (LOC57801) 0.0425467 1.10264
NM_018651 Zinc ﬁnger protein (ZFP) 1.22E-05 1.06137
NM_005245 Fat tumor suppressor homolog 1 (Drosophila) (FAT) 1.17E-08 1.04874
NM_001999 Fibrillin 2 (Congenital contractural arachnodactyly) (FBN2) 0.0069706 1.03422
NM_014791 Likely ortholog of maternal embryonic leucine zipper kinase (KIAA0175) 0.00256177 0.952044
NM_005733 RAB6 interacting, kinesin-like (RABKINESIN6) (RAB6KIFL) 0.0221156 0.945128
NM_014621 Homeobox D4 (HOXD4) 0.0287928 0.909819
NM_018136 ASPM asp (abnormal spindle) homolog, microcephaly associated (Drosophila) (Homo sapiens) 0.00916607 0.904724
NM_020648 Twisted gastrulation (TSG) 0.00833501 0.851925
NM_016307 Paired related homeobox protein (PRX2) 0.00802912 0.844485
U43148 Human patched homolog (PTC) 8.51E-05 0.836385
NM_013401 RAB3A interacting protein (RABIN3)-like 1 (RAB3IL1) 0.00219661 0.780599
NM_004403 Deafness, autosomal dominant 5 (DFNA5) 0.00651228 0.772185
NM_002333 Low density lipoprotein receptor-related protein 3 (LRP3) 0.0267207 0.737564
NM_003311 Tumor suppressing subtransferable candidate 3 (TSSC3) 0.0373222 0.697632
NM_015507 EGF-like-domain, multiple 6 (EGFL6) 0.01067 0.67935
NM_016574 Dopamine receptor D2 (DRD2), transcript variant 2 0.0205857 0.65134
NM_022843 Protocadherin 20 (PCDH20) 0.0173535 0.644874
NM_005244 Eyes absent homolog 2 (Drosophila) (EYA2) 0.0375536 0.63049
NM_014782 Armadillo repeat protein ALEX2  0.0217291 0.61077PLoS Medicine  |  www.plosmedicine.org 0375 March 2008  |  Volume 5  |  Issue 3  |  e62
distinctive of mesenchymal cells 
[10]. They become migratory, down-
regulate the expression of cell adhesion 
molecules, primarily E-cadherin, 
lose their apical–basal polarity, and 
express mesenchymal molecules such 
as ﬁbronectin and N-cadherin [11,12]. 
EMT is a key process in embryogenesis, 
where it leads to the formation of a 
migratory mesenchyme that progresses 
along the primitive streak and 
populates new areas of the embryo 
that will develop into mesoderm and 
endoderm [11]. 
EMT May Contribute to the 
Fibroblast Expansion in IPF
An EMT-like process has been reported 
in cancer progression and metastasis, 
and in ﬁbrotic disorders [13–23]. 
Recently, EMT was also observed 
in lung ﬁbrosis by two groups that 
noticed numerous cells co-expressing 
epithelial and mesenchymal markers 
(thyroid transcription factor-1/α-
smooth muscle actin [24] or surfactant 
protein C/N-cadherin [25]) within the 
expanded interstitium in IPF lungs. 
Moreover, using a triple transgenic 
mouse reporter system, Kim et al. 
demonstrated that EMT plays an 
important role during lung ﬁbrogenesis 
and may be more widespread than 
previously thought [25]. 
While the mechanisms underlying 
EMT in IPF are still unclear, many 
EMT-related genes such as transforming
growth factor (TGF)-β3 [26,27], lymphoid
enhancer factor-1 (LEF-1) [28], and Slug,
a TGF-β target gene required for EMT, 
as in the developing chicken heart 
[27], are up-regulated in IPF lungs 
(Table 1). 
Bone Morphogenetic Proteins/
TGF-β Balance and EMT
Bone morphogenetic proteins (BMPs) 
and TGF-β belong to a superfamily of 
multifunctional cytokines that includes 
different isoforms with highly speciﬁc 
functions including wound healing, 
extracellular matrix remodeling, and 
the control of epithelial– mesenchymal 
interactions during embryogenesis 
[29,30]. Importantly, BMPs antagonize 
the effects of TGF-β regarding EMT 
and induce the inverse process of 
mesenchymal-to-epithelial transition 
[10]. In tubular epithelial cells, BMP-7 
reverses EMT by directly counteracting 
TGF-β-induced Smad-dependent cell 
signaling [31]. In kidney ﬁbrosis, this 
antagonism may lead to regeneration 
of injured tissues, suggesting that 
reversal of EMT may have therapeutic 
advantages and that ﬁbrosis may be 
reversible [31]. BMP-2 is decreased 
and BMP-4 is increased in IPF lungs, 
compared with controls (Table 1). 
More importantly, gremlin, the main 
BMP antagonist that modulates early 
limb outgrowth and patterning in the 
mouse embryo [32], is increased in 
IPF lungs [33]. Gremlin is also found 
in human diabetic nephropathy, 
where it colocalizes with TGF-β [34]. 
TGF-β induces gremlin expression 
in association with EMT in lung 
epithelial cells [33]. Taken together, 
these data suggest that increased 
TGF-β expression, decreased BMP-2 
expression, and active BMP inhibition 
by gremlin create an EMT-favoring 
environment in IPF lungs (Figure 1). 
The occurrence of EMT in the lung 
represents a dramatic shift in cellular 
phenotype and requires reversal of 
early embryonic programs. Unlike 
kidney development, where the 
tubular epithelium originates from 
Table 1. Continued
Gene Bank 
Accession Number
Gene Name t-Test p-Value Fold Change
Other developmental-associated genes, continued
NM_022893 B cell CLL/lymphoma 11A (Zinc ﬁnger protein) (BCL11A) 0.0138856 0.608572
NM_000312 Protein C (inactivator of coagulation factors VA and VIIIA) (PROC) 0.0239822 0.604936
NM_018197 Zinc ﬁnger protein 64 homolog (Mouse) (ZFP64) 0.00371607 0.553534
NM_005230 ETS-domain protein (SRF accessory protein 2) (ELK3) 0.00955442 0.537755
NM_014071 Nuclear receptor coactivator 6 (NCOA6) 0.00611656 0.484845
NM_004671 Protein inhibitor of activated STAT X (PIASX-BETA) 0.0228299 0.465709
NM_004460 Fibroblast activation protein-α (FAP-α) 0.0486455 0.462095
NM_005776 Cornichon-like (CNIL) 0.00647969 0.429757
NM_004804 WD40 protein CIAO1  0.0115512 0.42985
NM_021008 Suppressin (Nuclear deformed epidermal autoregulatory factor-1 [DEAF-1]-related) 0.00244376 0.418671
NM_016205 Platelet-derived growth factor C (PDGFC) 0.0135145 0.411603
NM_016607 ALEX3 protein (ALEX3) 0.0287724 0.405413
NM_001797 Cadherin 11, type 2 (CDH11), transcript variant 1 0.0220489 0.365774
NM_006246 Protein phosphatase 2, regulatory subunit B (B56), epsilon isoform (PPP2R5E) 0.0322446 0.345418
NM_019035 Protocadherin 18 (PCDH18) 0.0383627 0.325794
NM_003454 Zinc ﬁnger protein 200 (ZNF200) 0.0138594 0.296512
NM_003457 Zinc ﬁnger protein 207 (ZNF207) 0.0384906 0.280163
NM_005657 Tumor protein P53 binding protein 1 (TP53BP1) 0.0325011 0.279415
From [5–7]. For complete datasets see http://www.dom.pitt.edu/paccm/Genomics/data.htm.
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cells that undergo mesenchymal-to-
epithelial transition [35,36], in the 
lung the formation of the various 
cell types lining the proximal and 
distal airways occurs through the 
differentiation of the epithelial 
precursor cells [37]. In other words, 
it may be more “natural” for kidney 
epithelial cells to undergo EMT than 
for lung epithelial cells. In fact, Snail
activation is sufﬁcient to induce EMT 
and kidney ﬁbrosis in adult transgenic 
mice [38]. Thus, EMT in IPF probably 
represents a dramatic reprogramming 
of epithelial cells [39].
The Wnt Signaling Pathway
Wnts comprise a large family of 
secreted glycoproteins that activate 
multiple distinct types of intracellular 
signaling pathways through canonical 
and noncanonical Wnt pathways [40]. 
Wnt signaling regulates a wide range 
of developmental processes, and its 
aberrant activation can lead to disease 
[41,42]. Canonical Wnt signaling 
inhibits the phosphorylation and 
degradation of β-catenin, allowing 
its translocation into the nucleus 
and its interaction with the high 
mobility group domain–containing, 
DNA-binding proteins (including 
the previously mentioned LEF-1) 
to regulate target gene expression 
[40–42]. β-catenin inﬂuences epithelial 
cell differentiation in the lung, and is 
required for the normal differentiation 
of the bronchiolar and alveolar 
epithelium [43]. 
Several Wnt genes are expressed 
during lung development. Wnt7b-
deﬁcient mice exhibit impaired 
alveolar type I cell differentiation, 
have hypoplastic lungs, and die at 
birth of respiratory failure [44]. 
Similarly, Wnt5a-deﬁcient mice also 
die shortly after birth from respiratory 
failure, but in contrast to Wnt7a-
deﬁcient mice, they exhibit increased 
proliferation of lung epithelial and 
mesenchymal compartments [45,46]. 
Interestingly, Wnt5a-null embryos 
showed increased expression of Sonic 
hedgehog (Shh), suggesting that 
Wnt5a signaling is required for the 
normal down-regulation of Shh, and 
that in the absence of Wnt5a, Shh-
induced mesenchymal proliferation 
continues in late gestation. As will 
be discussed, epithelial expression of 
Shh has also been found in IPF lungs 
[47,48]. 
The Wnt Signaling Pathway in IPF
Using gene expression microarrays, 
we demonstrated up-regulation of 
several members of the Wnt signaling 
pathway in IPF lungs, compared either 
with normal lungs or other interstitial 
lung diseases [3,5] (Table 1). For 
example, WISP-1 and the secreted 
frizzled-related protein 2 are increased 
in IPF compared with hypersensitivity 
pneumonitis [3]. Several other 
Wnt pathway-related genes are also 
overexpressed in IPF lungs compared 
to normal controls (Table 1; dataset 
used in [6]; Gene Expression Omnibus 
database serial accession number 
GSE2052). The overall balance of the 
Wnt pathway genes overexpressed in 
IPF lungs seems to favor activation 
of the canonic pathway (Figure 2). 
To date, there is only one study 
that directly demonstrated aberrant 
nuclear localization of β-catenin in 
bronchiolar/alveolar epithelial cells 
and in ﬁbroblasts from the ﬁbroblastic 
foci in IPF lungs [49]. Activation 
of β-catenin in epithelial cells is 
also indirectly corroborated by the 
doi: 10.1371/journal.pmed.0050062.g001
Figure 1. Schematic Overview of the Epithelial–Mesenchymal Transition as Modulated by 
TGF-β and BMPs
In IPF lungs, TGF-β3, gremlin, and LEF-1 are up-regulated, while BMP-2 is down-regulated. 
Dysregulation of TGF-β/BMP pathway induces a ﬁbrotic phenotype. EMT, so important in 
development, is likely to represent one possible response of the alveolar epithelial cell facing 
sustained injury. Increased expression of BMPs may not only antagonize TGF-β-induced EMT, 
enhancing re-epithelialization, but also may cause the opposite process, mesenchymal-to-
epithelial transition (MET).
Five Key Papers in the Field
Armanios et al., 2007 [59] Mutations 
of genes encoding telomerase reverse 
transcriptase and telomerase RNA 
support the idea that pathways leading 
to telomere shortening are involved in 
the pathogenesis of familial idiopathic 
pulmonary ﬁbrosis.
Selman et al., 2006 [3] This was 
the ﬁrst paper to compare the gene 
expression proﬁle of different interstitial 
lung diseases, providing evidence 
that idiopathic pulmonary ﬁbrosis is 
characterized by a distinct transcriptional 
signature.
Thiery and Sleeman, 2006 [10] 
In this detailed review on epithelial 
cell plasticity, the authors dissect the 
molecular events during which epithelial 
cells are transformed into mesenchymal 
cells and vice versa.
Koli et al., 2006 [33] Findings 
suggest that overexpression of the BMP 
inhibitor gremlin may play a role in the 
pathogenesis of IPF, and may function 
to enhance the ﬁbrotic response by 
modulating BMP-4 signaling in the lung.
Willis et al., 2005 [24] The authors 
demonstrate for the ﬁrst time the 
epithelial–mesenchymal transition in 
idiopathic pulmonary ﬁbrosis.PLoS Medicine  |  www.plosmedicine.org 0377 March 2008  |  Volume 5  |  Issue 3  |  e62
overexpression of downstream genes 
such as MMP-7 and osteopontin [5,6], 
and may also be related to EMT. 
Taken together, these data suggest 
a signiﬁcant role for the Wnt pathway 
in IPF. 
Fibroblast Expansion in IPF: 
Mirroring Aggressive Fibromatosis?
A key process in the development of 
IPF is the formation of the ﬁbroblastic 
focus. It has been suggested that these 
foci represent discrete isolated foci of 
ﬁbroblasts/myoﬁbroblasts. However, 
using three-dimensional reconstruction 
of the IPF lungs, other studies have 
suggested that ﬁbroblast foci are the 
leading edge of a complex reticulum 
that is highly interconnected extending 
from the pleura into the underlying 
parenchyma [50].
It is increasingly apparent that 
mesenchymal cells in ﬁbroblastic foci 
in IPF exhibit a variety of abnormalities 
compared to normal lung ﬁbroblasts 
or ﬁbroblasts from other lung diseases. 
Some of these abnormalities are 
related to Wnt pathway signaling or 
to up-regulation of genes present in 
exaggerated ﬁbroplasias. β-catenin 
stabilization (as observed in IPF) 
has been reported in hyperplastic 
cutaneous wounds, in keloid scars, 
and in aggressive ﬁbromatosis, among 
other disorders [51–53]. Furthermore, 
transgenic mice that express stabilized 
β-catenin in mesenchymal cells develop 
aggressive ﬁbromatosis suggesting a 
common role for β-catenin in abnormal 
ﬁbrotic responses [52]. These ﬁndings 
raise the possibility that unchecked 
activation of a process important 
in normal wound healing causes 
abnormal ﬁbroproliferative processes. 
Aggressive ﬁbromatosis is a soft 
tissue tumor composed of a clonal 
population of mesenchymal, spindle-
shaped cells. It is locally invasive, 
but rarely metastasizes. Microarray 
analysis identiﬁed four genes uniquely 
overexpressed in this disorder: 
ADAM12, WISP-1, SOX-11, and ﬁbroblast
activation protein-alpha (FAP-α) [54]. 
WISP-1 and several members of the 
SOX family are up-regulated in IPF 
[3]. FAP-α is selectively expressed by a 
subset of ﬁbroblasts in areas of ongoing 
tissue injury in IPF lungs, but not in 
normal lung tissue or in tissue with 
centriacinar emphysema [55]. FAP-
α is a type II transmembrane serine 
protease expressed at sites of tissue 
remodeling in embryonic development 
[56,57]. FAP-α is highly expressed on 
reactive stromal ﬁbroblasts in over 
90% of human epithelial cancers, in 
healing wounds, and in sarcomas, but 
is not detected in ﬁbroblasts of benign 
epithelial tumors or normal adult 
tissues [57,58]. 
An additional analogy between 
IPF and aggressive ﬁbromatosis is 
the recent evidence that suggests 
involvement of pathways leading 
to telomere shortening in the 
pathogenesis of both disorders 
[59–61]. Telomeres are noncoding 
DNA sequences at the end of 
eukaryotic chromosomes that maintain 
chromosomal integrity and prevent 
replication of defective genes [62]. 
When normal cells reach a critical 
telomere length, they exit the cell cycle 
and undergo senescence. The putative 
relationship between telomerase and 
human disease is demonstrated in 
two opposite situations. On one side 
of the spectrum, most human cancers 
are characterized by the expression of 
telomerase, which helps to maintain 
telomere length and enhance 
indeﬁnite cell proliferation [63]. 
On the other side of the spectrum, 
in pulmonary ﬁbrosis and aggressive 
ﬁbromatosis, telomerase activity seems 
to be diminished, with consequent 
premature telomere shortening. Two 
recent reports demonstrated that 
mutations in the genes encoding 
telomerase components are detected 
in patients with familial IPF, and 
occasionally in patients with sporadic 
IPF [59,60]. According to these 
studies, pulmonary ﬁbrosis may be at 
least partially related to a telomerase 
deﬁciency and short dysfunctional 
telomeres, which after DNA damage 
leads to cell death or cell-cycle arrest. 
doi: 10.1371/journal.pmed.0050062.g002
Figure 2. Changes in the Expression of Genes Known to be Involved in the Canonical Wnt 
Pathway
The ﬁgure was generated using Ingenuity Pathways Analysis (Ingenuity Systems, http://www.
ingenuity.com/). Increased genes are in increasing shades of red, decreased are in increasing 
shades of green. Combined red and green is when different members are changed in different 
directions.PLoS Medicine  |  www.plosmedicine.org 0378 March 2008  |  Volume 5  |  Issue 3  |  e62
Interestingly, cigarette smoking, a 
strong environmental risk factor for 
IPF, causes telomere shortening in a 
dose-dependent manner [64]. Since 
alveolar epithelial cells play a critical 
role in the pathogenesis of IPF, and 
telomerase expression is generally 
restricted to cells with the capacity 
to proliferate, it has been speculated 
that ﬁbrotic response in patients with 
short telomeres is provoked by a loss 
of alveolar cells [59], which may be 
enhanced by exposure to cigarette 
smoke.
Naturally, there are many differences 
between aggressive ﬁbromatosis and the 
ﬁbroblastic foci of IPF, primarily the 
clonality of cells; however, some of the 
pathways that are activated in the former 
may also participate in the latter. 
Phosphatase and Tensin Homologue 
Deleted on Chromosome 10
Phosphatase and tensin homologue 
deleted on chromosome 10 (PTEN)
is a phosphatidylinositol phosphate 
phosphatase that is frequently deleted 
or inactivated in human cancers [65]. 
PTEN is critical in development, and 
PTEN-null embryos die early during 
embryogenesis [66,67]. 
Signiﬁcant to our discussion, 
a critical role for PTEN in the 
orchestrated death and removal 
of myoﬁbroblasts has been 
suggested. In response to collagen 
matrix contraction, PTEN triggers 
ﬁbroblast apoptosis by leading to 
decreased PI3 kinase activity and Akt 
phosphorylation [68]. Myoﬁbroblasts 
from IPF ﬁbroblastic foci undergo 
decreased apoptosis compared to 
myoﬁbroblasts from ﬁbromyxoid 
lesions of cryptogenic organizing 
pneumonia, a potentially reversible 
lung disorder [69,70]. Impaired 
apoptosis may be at least partially 
associated with the decreased 
expression of PTEN observed in IPF 
lungs [71]. Additionally, since PTEN 
suppresses ﬁbroblast differentiation 
to myoﬁbroblasts [71], its reduced 
expression in IPF ﬁbroblastic foci may 
have a dual deleterious effect, inducing 
myoﬁbroblast differentiation and 
increasing survival. 
Importantly, the PTEN/PI3 kinase/
Akt signaling pathway is a critical 
regulator of the interconnection 
between the TGF-β/Smad, Wnt/β-
catenin, and BMP pathways [72–75]. 
Sonic Hedgehog
Sonic (Shh), Indian (Ihh), and Desert 
(Dhh) are the hedgehog family 
members in mammals. Shh is expressed 
in the developing lung epithelium, and 
its primary receptor, Patched-1 (Ptc), 
is found in mesenchymal cells. In vitro 
and in vivo studies have shown that 
Shh increases the proliferation of lung 
mesenchymal cells, up-regulating the 
expression of smooth muscle actin and 
myosin [45].
In developing mice, Shh produced by 
the epithelium stimulates mesenchymal 
cell proliferation and differentiation, 
and importantly, its overexpression 
causes an aberrant increase in the ratio 
of interstitial mesenchyme to epithelial 
tubules [76,77]. 
In this context, a pattern of strong 
Shh expression has been identiﬁed 
in reactive alveolar epithelial cells 
as well as in epithelial cells lining 
the honeycomb cysts in IPF lungs 
[47,48], while microarrays indicated 
up-regulation of its primary receptor 
(Table 1), suggesting that the Shh 
pathway is activated on in this disease. 
Therapeutic Implications 
Identiﬁcation and targeting of these 
abnormal mediators/pathways will 
eventually allow the development of 
therapeutic agents to control and 
The Wnt signaling pathway: A 
signaling pathway that is involved in 
embryogenesis. Elimination of Wnt 
causes development of wingless fruit 
ﬂies, hence the name Wnt (Wingless 
type). The central player in the signaling 
cascade of the canonical Wnt pathway 
is β-catenin. Nuclear β-catenin interacts 
with transcription factors such as LEF-
1/T cell–speciﬁc transcription factor to 
affect transcription. Most Wnts work 
through speciﬁc receptors (Frizzled 
family of receptors and LRP5/6 co-
receptors) and affect degradation and 
nuclear localization of β-catenin. In 
adults, dysregulation of the Wnt pathway 
leads to a variety of abnormalities and 
degenerative diseases, including cancer 
and ﬁbrosis.
TGF-β signaling: The TGF-β superfamily 
of growth factors that includes TGF-
β, activins, and BMPs regulates a 
plethora of biological processes during 
embryonic development as well as in 
adult life. A common mechanism through 
Smad activation applies to signaling 
mediated by all TGF-beta superfamily 
members. However, TGF-β ligands signal 
preferentially through Smad-2 and -3, 
whereas BMP signaling is mediated 
through Smad-1, -5, and -8. TGF-β and 
BMPs have opposite effects in a number 
of processes. Importantly, TGF-β has a 
proﬁbrotic effect and induces epithelial–
mesenchymal transition, while several 
BMPs display the contrary effect. 
PTEN/PI3 kinase/Akt signaling 
pathway: The development and 
function of many tissues that feature 
tubular networks, including the lung, 
are regulated by intricate programs of 
epithelial cell morphogenesis. PTEN 
controls epithelial morphogenesis, 
integrating cellular polarity with tissue 
architecture. In the adult life, PTEN is 
an important tumor suppressor, and 
its dysfunction has been associated 
with cancer susceptibility. Importantly, 
PTEN becomes activated during wound 
healing, promoting ﬁbroblast apoptosis. 
Decreased PTEN expression is found in 
IPF ﬁbroblasts, which may enhance their 
survival, causing active ﬁbroblastic foci 
persistence.
Hedgehog signaling pathway: A
pathway critical in development. 
The pathway is named after its main 
ligand hedgehog. Sonic hedgehog 
is a morphogen that can specify 
multiple cell identities as a function 
of its concentration. In the lungs, Shh 
participates in branching morphogenesis, 
controlling bud size and shape. Lung-
speciﬁc overexpression of Shh results 
in severe increase of interstitial tissue. 
Strong Shh expression has been 
identiﬁed in reactive alveolar epithelial 
cells in IPF lungs.
Cross-talk pathways: Emerging
evidence supports the theory that the 
cell response to extrinsic signals relies not 
only on the effect of a single pathway, 
but on the integration of numerous 
signals from a plethora of cross-talking 
pathways. In this context, TGF-β/Smad, 
Wnt/β-catenin, BMP, PTEN, and members 
of the hedgehog and other families 
of secreted factors pathways operate 
through complex interconnections and 
feedback loops.
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hopefully achieve regression of IPF 
remodeling. Strategies designed to 
target the ﬁbrogenic action of TGF-
β with agents blocking its signaling 
pathway, such as the BMP-7, have 
led to repair of severely damaged 
renal tubular epithelial cells and to 
improvement of renal function and 
survival in mice with nephrotoxic 
serum nephritis [78]. Along the same 
line of thought, hepatocyte growth 
factor, which among other functions 
inhibits TGF-β-induced EMT, may also 
be a useful therapeutic approach. It was 
recently shown that in vivo hepatocyte 
growth factor gene transfer reduced 
bleomycin-induced pulmonary ﬁbrosis, 
improving alveolar epithelial repair, 
and importantly, decreasing TGF-β1 
expression [79]. 
Conclusion
Many pathways that play an 
essential role during embryological 
development are inactivated later in 
life, although some of them may be 
transiently expressed during adult 
repair. Aberrant activation of these 
pathways during adult homeostasis 
leads to pathological events resulting 
in cancer, but may also be associated 
with the development of idiopathic 
pulmonary ﬁbrosis. Dysfunctional 
activation of embryological pathways 
regularly repressed in the adult life 
may explain the persistent nature of 
the disease. Although some progress 
into unraveling the pathogenic 
mechanisms involved in IPF has been 
made, many open questions remain, 
and virtually no effective treatment 
is currently available. Designing and 
implementing interventions that target 
these embryological pathways may be 
required to develop novel anti-IPF 
therapies and to signiﬁcantly improve 
the outcome of IPF patients.  
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